Prestige Consumer Healthcare Inc. (PBH)

Prestige Consumer Healthcare Inc. (PBH) is a healthcare company (drug manufacturers - specialty & generic) based in the United States. The share price is $48.48, up 1.00% on the day, which values the company at $2.3B. Price as of 17 Nov 2026, 17:29 UTC, from Yahoo Finance.

Key facts

Share price
$48.48+1.00% today
Market value
$2.3B
P/E ratio
15.0×last 12 months
Forward P/E
9.5×
Funk Score
54/100
Against its own history
Below its usual priceusual price $61.39
200-week average
$65.1726% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Prestige Consumer Healthcare Inc. in more detail

PBH trades at 15.0× its last twelve months' earnings, 9.5× next year's expected earnings, 2.0× sales. Measured against its own history, the price is 21% below what its usual multiples would imply ($61.39) — below its usual price. It sits 26% below its 200-week average of $65.17.

Over the last five fiscal years Prestige Consumer Healthcare Inc. has compounded revenue 2.9% a year, earnings per share 3.8% a year, free cash flow 2.9% a year. Its Funk Score is 54 out of 100 (financial strength 3.8, profitability 6.7, growth 2.9, value 8.1, each out of 10).

3 of the superinvestors tracked here hold PBH, including John Rogers (2.4% of the portfolio), Charles Brandes (founder) (0.7% of the portfolio), Lee Ainslie (0.0% of the portfolio).

Superinvestors holding PBH

3 of the investors tracked here report a position in their latest 13F filing.

Prestige Consumer Healthcare Inc. (PBH): questions and answers

What is PBH's P/E ratio?

Prestige Consumer Healthcare Inc. trades at 15.0× its last twelve months' earnings and 9.5× next year's expected earnings. At its fiscal year-ends over the past 15 years the P/E ranged from 5.3× to 42.7×, with a median of 19.6×.

What is PBH's PEG ratio?

Prestige Consumer Healthcare Inc.'s PEG ratio is 1.31 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is Prestige Consumer Healthcare Inc.'s market cap?

Prestige Consumer Healthcare Inc. is valued at $2.3B at a share price of $48.48.

Is PBH overvalued or undervalued?

Against its own history, PBH is below its usual price: the price is 21% below the $61.39 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is PBH above its 200-week moving average?

No. PBH is 25.6% below its 200-week average of $65.17. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Prestige Consumer Healthcare Inc. growing?

Over the last five fiscal years Prestige Consumer Healthcare Inc.'s revenue grew 2.9% a year and its earnings per share 3.8% a year; over ten years revenue grew 3.0% a year.

Cite this page

Funkfolio, “Prestige Consumer Healthcare Inc. (PBH) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/PBH

Underlying data: Yahoo Finance; company filings with the SEC.